Together, these results suggest that lineage-specific TFs are largely expressed in clinical SCLC specimens in a mutually exclusive manner at the tumor level, whereas this principle applies more at the cellular level for ASCL1 and NEUROD1 expression. This evidence concerns the gene NEUROD1 and neoplasm.